Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - emulsion for infusion - glycine 5.67 g / 1000 ml; l- alanine 11.39 g / 1000 ml; l-histidine 2.64 g / 1000 ml; l-arginine 6.33 g / 1000 ml; l- methionine 2.20 g / 1000 ml; l- lysine as hydrochloride 3.19 g / 1000 ml; l- isoleucine 3.30 g / 1000 ml; l- threonine 2.31 g / 1000 ml; l- tryptophan 0.99 g / 1000 ml; l- proline 3.74 g / 1000 ml; l- phenylalanine 3.08 g / 1000 ml; l- valine 3.19 g / 1000 ml; l- tyrosine 0.22 g / 1000 ml; l- leucine 4.02 g / 1000 ml; l- serine 2.75 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 2.45 g / 1000 ml; refined soya-bean oil 100 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 200 g / 1000 ml; potassium chloride 2.98 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined soya-bean oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - emulsion for infusion - refined soya-bean oil 200.00 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 250.00 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.06 g / 1000 ml; l- tyrosine 0.28 g / 1000 ml; l- tryptophan 1.26 g / 1000 ml; l- threonine 2.94 g / 1000 ml; l- serine 3.50 g / 1000 ml; l- proline 4.76 g / 1000 ml; l- phenylalanine 3.92 g / 1000 ml; l- methionine 2.80 g / 1000 ml; l- lysine as hydrochloride 4.06 g / 1000 ml; l- leucine 5.11 g / 1000 ml; l- isoleucine 4.20 g / 1000 ml; l-histidine 3.36 g / 1000 ml; glycine 7.21 g / 1000 ml; l-arginine 8.05 g / 1000 ml; l- alanine 14.49 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride hexahydrate; potassium chloride; refined olive oil; sodium acetate trihydrate; sodium glycerophosphate pentahydrate - emulsion for infusion - l- alanine 17.60 g / 1000 ml; refined olive oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 300 g / 1000 ml; magnesium chloride hexahydrate 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate pentahydrate 5.36 g / 1000 ml; sodium acetate trihydrate 6.12 g / 1000 ml; l- valine 4.93 g / 1000 ml; l- tyrosine 0.34 g / 1000 ml; l- tryptophan 1.53 g / 1000 ml; l- threonine 3.57 g / 1000 ml; l- serine 4.25 g / 1000 ml; l- proline 5.78 g / 1000 ml; l- phenylalanine 4.76 g / 1000 ml; l- methionine 3.40 g / 1000 ml; l- lysine as hydrochloride 4.93 g / 1000 ml; l- leucine 6.21 g / 1000 ml; l- isoleucine 5.10 g / 1000 ml; l-histidine 4.08 g / 1000 ml; glycine 8.76 g / 1000 ml; l-arginine 9.78 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium chloride; potassium chloride; refined soya-bean oil; sodium acetate dihydrate; sodium glycerophosphate - emulsion for infusion - refined soya-bean oil 200 g / 1000 ml; calcium chloride dihydrate 0.74 g / 1000 ml; glucose as monohydrate 4000.00 g / 1000 ml; magnesium chloride 1.12 g / 1000 ml; potassium chloride 4.47 g / 1000 ml; sodium glycerophosphate 5.36 g / 1000 ml; sodium acetate dihydrate 6.12 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - English - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine as hydrochloride; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; refined soya-bean oil - emulsion for infusion - refined soya-bean oil 200 g / 1000 ml; glucose as monohydrate 400 g / 1000 ml; l- valine 5.80 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 1.80 g / 1000 ml; l- threonine 4.20 g / 1000 ml; l- serine 5.00 g / 1000 ml; l- proline 6.80 g / 1000 ml; l- phenylalanine 5.60 g / 1000 ml; l- methionine 4.00 g / 1000 ml; l- lysine as hydrochloride 5.80 g / 1000 ml; l- leucine 7.30 g / 1000 ml; l- isoleucine 6.00 g / 1000 ml; l-histidine 4.80 g / 1000 ml; glycine 10.30 g / 1000 ml; l-arginine 11.50 g / 1000 ml; l- alanine 20.70 g / 1000 ml - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - diltiazem hydrochloride - tablets - diltiazem hydrochloride 60 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - darunavir - film coated tablets - darunavir 800 mg - darunavir - darunavir teva co-administered with 100 mg ritonavir and with other antiretroviral agents,is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for patients over 18 years of age.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - darunavir - film coated tablets - darunavir 600 mg - darunavir - darunavir teva co-administered with 100 mg ritonavir, and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

teva pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains baclofen 10,0 mg

Israel - English - Ministry of Health

teva israel ltd - filgrastim - solution for injection / infusion - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to reduce the incidence and duration of infection-related events. tevagrastim in indicated for the treatment of persistent neutopenia (anc less than or equal to 1.0 x 1000000000/l ) in patients with advanced hiv infection in order to reduce the risk of bacterial infections when other options to manage neutopenia are inappropriate.